Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life
Language
EN
Article de revue
This item was published in
Erj Open Research. 2024-07-08, vol. 10, n° 4, p. 00976-2023
English Abstract
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, ...Read more >
Half of severely asthmatic adolescents treated with omalizumab transitioning to adulthood discontinue the treatment, suggesting insufficient asthma control. However, most of the other half have low rates of HCRU markers, their asthma being under control. https://bit.ly/49ixpxt.Read less <